Alta Fundamental Advisers LLC 13D and 13G filings for Milestone Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-07-16 6:06 pm Purchase | 2024-07-14 | 13D | Milestone Pharmaceuticals Inc. MIST | Alta Fundamental Advisers LLC | 2,658,589 4.990% | 987,300 (+59.07%) | Filing |
2023-11-09 4:43 pm Purchase | 2023-11-06 | 13D | Milestone Pharmaceuticals Inc. MIST | Alta Fundamental Advisers LLC | 1,671,289 5.000% | 1,671,289 (New Position) | Filing |